market surveillance

Latest Articles

ARTICLE

Happy 2025 – more churn for MDR and IVDR!

Erik Vollebregt

Happy new year everyone! I hope you had a good rest over the holidays because 2025 will be interesting. I am planning to revive this blog this year and hope to put new energy in it by making it more periodical with smaller bits of information and shorter analysis. You will still get my unique […]
Filter articles on Medical Devices Legal
Filter articles on Axon
ARTICLE

Impossible and Incredible And Yet Really Happened

Karin Verzijden What can we learn from the Impossible vs. Incredible case in the Netherlands? At the end May this year, the Court of The Hague rendered a remarkable judgment: at the request of Impossible Foods, Nestlé was banned from launching its INCREDIBLE BURGER in the EU. How is this possible? Impossible Foods is not even on […]
Filter articles on Food Health Legal

More Articles

Article

Managing the 2024 MDR danger zone – and outlines of a potential solution in MDCG 2022-11

, Erik Vollebregt

We live in interesting times for medical devices in the Union – some have said we are headed for a cliff edge at the end of the grace period. I would personally prefer to say that we are in the danger zone, which would be a zone of danger (Archer pun on Top Gun), but […]

Navigate through our knowledgebase

advertisingappsauthorised representativeBorderlinebusiness complianceCE MarkCE markingClinical evaluationClinical investigationClinical TrialsCybersecurityData ProtectioneHealthenforcementENVIEucomedEudamedfoodhealthhealth claimsIn vitro diagnosticsinformationIVDIVDRivdslabellingLiesemarket surveillanceMDRMEDDEVMedical devicesmhealthNotified Bodiesnotified bodyNovel Foodnutrition claimspersonal dataPMAPMSprivacyQuality systemRecastreprocessingrevisionRoth-BehrendtSoftwarestandardstechnologyUDIUnannounced audits